Other
Net Change in Cash
Vertex Pharmaceuticals Net Change in Cash increased by 197.9% to $417.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 268.5%, from $113.20M to $417.10M. Over 2 years (FY 2022 to FY 2025), Net Change in Cash shows a downward trend with a -61.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementCash Flow Statement
SectionOther
CategoryLiquidity
SignalHigher is better
VolatilityVolatile
First reportedQ1 2015
Last reportedQ1 2026May 5, 2026
How to read this metric
A positive change indicates net cash generation, while a negative change indicates cash consumption for the period.
Detailed definition
The total net increase or decrease in cash, cash equivalents, and restricted cash during the reporting period. It is the...
Peer comparison
A fundamental liquidity metric used to compare cash management efficiency across all public companies.
Metric ID:
net_change_in_cashHistorical Data
18 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $209.10M | $519.90M | $803.90M | $1.10B | $472.90M | $1.34B | -$1.22B | -$34.93M | $963.20M | -$744.30M | -$1.20B | -$4.58B | -$675.90M | $113.20M | $296.60M | $0.00 | $140.00M | $417.10M |
| QoQ Change | — | +148.6% | +54.6% | +36.8% | -57.0% | +182.3% | -191.1% | +97.1% | >999% | -177.3% | -61.6% | -280.6% | +85.2% | +116.7% | +162.0% | -100.0% | — | +197.9% |
| YoY Change | — | — | — | — | +126.2% | +156.8% | -251.3% | -103.2% | +103.7% | -155.8% | +1.1% | <-999% | +9.2% | +109.4% | +106.5% | — | +120.7% | +268.5% |
Range-$4.58B – $1.34B
CAGR+17.6%
Avg YoY Growth-962.9%
Median YoY Growth+103.7%
Current Streak2 quarters growth
Net Change in Cash at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's net change in cash?
- Vertex Pharmaceuticals (VRTX) reported net change in cash of $417.10M in Q1 2026.
- How has Vertex Pharmaceuticals's net change in cash changed year-over-year?
- Vertex Pharmaceuticals's net change in cash increased by 268.5% year-over-year, from $113.20M to $417.10M.
- What is the long-term trend for Vertex Pharmaceuticals's net change in cash?
- Over 2 years (2022 to 2025), Vertex Pharmaceuticals's net change in cash has grown at a -61.5% compound annual growth rate (CAGR), from $3.71B to $549.80M.
- What does net change in cash mean?
- The total change in the company's cash position over the period.